Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease release » increased release (Expand Search)
marked decrease » marked increase (Expand Search)
mean decrease » a decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease release » increased release (Expand Search)
marked decrease » marked increase (Expand Search)
mean decrease » a decrease (Expand Search)
-
1
-
2
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”
-
3
-
4
Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index.
Published 2025“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”
-
5
-
6
MS decreases the larger amplitude distribution in adult rats.
Published 2023Subjects: “…glutamatergic events decreased…”
-
7
-
8
Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation.
Published 2020“…The error bars for all data presented in Fig 3 represent the mean ± SEM. Results demonstrate that TPP derivatives preferentially accumulate in mitochondria; decrease mitochondria membrane potential and ATP-linked oxygen consumption; and increase DHE oxidation. …”
-
9
The apparent Ca<sup>2+</sup> affinity of release is decreased by hydrophobic mutations.
Published 2020“…<b>B,</b> Ca<sup>2+</sup> curves normalized to maximum EJP amplitude predicted by the nonlinear regression. The significant rightward shift in the curve (EC50, non overlapping confidence intervals) indicates a decrease in the apparent Ca<sup>2+</sup> affinity of neurotransmitter release.…”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20